This compound is primarily utilized in organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various bioactive molecules, particularly in the creation of drugs targeting neurological disorders and cancer. Its structure, featuring both a bromopyridine and cyclobutanol moiety, allows for versatile chemical modifications, making it valuable in constructing complex molecular frameworks. Additionally, it is employed in the study of enzyme inhibition and receptor binding, aiding in the discovery of novel therapeutic agents.